Lyrica (pregabalin) — CareFirst (Caremark)
Postherpetic neuralgia
Preferred products
- gabapentin immediate-release
Initial criteria
- The request is for one of the listed drugs
- If Lyrica oral solution—patient has difficulty swallowing oral solids OR requires a dose not obtainable via capsules
- Patient experienced inadequate response, intolerance, or contraindication to gabapentin immediate-release
Reauthorization criteria
- Request is for one of the listed drugs
- If Lyrica oral solution—patient has difficulty swallowing oral solids OR requires a dose not obtainable via capsules
- Patient has achieved or maintained a positive clinical response to the requested drug
Approval duration
12 months